EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulating regulated cell death: mechanistic insights into traditional Chinese medicine metabolites for ischemia/reperfusion-induced acute kidney injury

Shaowu Zhang, Jiawen Deng, Tongtong Ma, Jixin Tang, Liping Ou, Peng Wang, Betty Yuen Kwan Law, Huafeng Liu

Frontiers in Pharmacology · 02.07.2026 · 17

DOI: 10.3389/fphar.2026.1779205 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.07.2026. Verfasst von Shaowu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Lo…. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI), characterized by a rapid decline in renal function, represents a significant global health burden due to its high mortality and frequent progression to chronic kidney disease (CKD). Ischemia/reperfusion (I/R) injury is a major cause of AKI, yet clinically effective pharmacotherapies remain elusive. The pathogenesis of I/R-AKI is critically driven by regulated cell death (RCD) pathways—including apoptosis, ferroptosis, pyroptosis, and necroptosis—which mediate tubular epithelial damage and inflammatory responses. Consequently, targeting these RCD pathways emerges as a promising therapeutic strategy. Certain bioactive metabolites found in medicinal plants, including those used in traditional Chinese medicine (TCM), have demonstrated considerable potential in alleviating renal I/R injury. This review provides a detailed analysis of the mechanistic roles of key RCD pathways in I/R-AKI. Furthermore, it synthesizes preclinical evidence over recent decades to illustrate how specific TCM metabolites (e.g., hydroxysafflor yellow A, silibinin, salvianolic acid B, and gypenoside XLIX) confer renoprotection by modulating these RCD processes. To our knowledge, this work is the first to integrate the four major RCD pathways with a spectrum of TCM metabolites that modulate these processes in I/R-AKI. By presenting this integrated perspective, our review highlights TCM as a valuable repository for promising modulators of RCD pathways in I/R-AKI and outlines key priorities for future translational research.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injuryischemia/reperfusion injuryregulated cell deathrenoprotectiontraditional Chinese medicine metabolites

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
  • Department of Nephrology, National Clinical Key Specialty Construction Program (2023); Institute of Nephrology; Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases; Key Laborator…
  • Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, Guangdong, China.

Zitieren

APA

Zhang, S., Deng, J., Ma, T., Tang, J., Ou, L., Wang, P., Law, B. Y. K., & Liu, H. (2026). Modulating regulated cell death: mechanistic insights into traditional Chinese medicine metabolites for ischemia/reperfusion-induced acute kidney injury. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1779205

Vancouver

Zhang S, Deng J, Ma T, Tang J, Ou L, Wang P, et al. Modulating regulated cell death: mechanistic insights into traditional Chinese medicine metabolites for ischemia/reperfusion-induced acute kidney injury. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1779205

BibTeX
@article{Zhang2026,
  author = {Zhang, Shaowu and Deng, Jiawen and Ma, Tongtong and Tang, Jixin and Ou, Liping and Wang, Peng and Law, Betty Yuen Kwan and Liu, Huafeng},
  title = {Modulating regulated cell death: mechanistic insights into traditional Chinese medicine metabolites for ischemia/reperfusion-induced acute kidney injury},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1779205}
}
Kostenlos starten →